IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola
Bologna's university hospital, home of the Seràgnoli haematology institute and a leading Italian centre for myeloma, lymphoma and CAR-T.
Overview
The Policlinico Sant'Orsola is the university hospital of the world's oldest university and an IRCCS for transplant and oncology. Its Seràgnoli Institute of Haematology, associated with Michele Cavo (myeloma), Pier Luigi Zinzani (lymphoma) and the GIMEMA cooperative group, has run pivotal Italian trials in myeloma transplantation and lymphoma and is one of Italy's principal CAR-T and allogeneic transplant centres. Medical oncology under Andrea Ardizzoni is active in thoracic and gastrointestinal trials, and the hospital has large paediatric oncology, surgical oncology and nuclear medicine departments. The Emilia-Romagna regional network links it with IRST Meldola.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, including child institutions. 576 works · 5,172 citations · 71% open access · 9% clinical trials · 8% reviews.
- Riccardo Casadei60 works
- Emi Dika56 works
- Claudio Ricci43 works
- Lorenzo Fuccio42 works
- Andrea Ardizzoni36 works
- Carlo Ingaldi32 works
- Laura Alberici29 works
- Pier Luigi Zinzani29 works
- Francesco Massari27 works
- Vincenzo D’Ambra27 works
- Seràgnoli haematology institute
- Myeloma and lymphoma trials (GIMEMA)
- CAR-T and transplantation
- Thoracic oncology
- Paediatric oncology
Similar pages
not linked directly; found by shared links- PairingRituximab pretreatment before ibritumomab tiuxetan (Zevalin)
Shares CD20, Diffuse large B-cell lymphoma.
- AgentRituximab
Shares CD20, Diffuse large B-cell lymphoma.
- IndicationFollicular lymphoma
Shares CD20, Diffuse large B-cell lymphoma.